As of May 27
| +0.67 / +5.70%|
The 9 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 29.00 and a low estimate of 12.00. The median estimate represents a +28.82% increase from the last price of 12.42.
The current consensus among 9 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.